Ambrisentan
- Manufacturer
- Veranova, L.P.
- Effective date
- 2026-01-06
- Label type
- BULK INGREDIENT
- Version
- 7
- Source
- full-release
- Hydrated at
- 2026-06-01 02:52:17
Label at a glance#
ProductAmbrisentan
Active ingredientAMBRISENTAN
Label structure1 sections
Label contents#
Full prescribing information#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| AMBRISENTAN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d7db2b61-402f-f2c9-6e9c-10d81037d0ba | Product name | 3 | 20230126 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50137-4051-1 | 2021-12-16 | C162847 | 48780-1 | ba0f9c33-5d45-a910-e053-dadaa90a0b85 | Ambrisentan (4051.F) |
| 50137-4051-1 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-5d45-a910-e053-dadaa90a0b85 | Ambrisentan (4051.F) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50137-4051-1 | Ambrisentan | 1 kg in 1 CONTAINER | POWDER | 1 | 7 |
Products#
Every source-derived product name is available through these pages.
- Ambrisentan
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 50137-4051 | 50137-4051-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| AMBRISENTAN | HW6NV07QEC | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ambrisentan | AMBRISENTAN | Apotex Corp. | 291a782a-77e1-8a8e-e1c8-2626f305c2b7 | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | Ambrisentan AMBRISENTAN |
| Ambrisentan | AMBRISENTAN | Zydus Pharmaceuticals USA Inc. | 37af3191-0ed3-4783-8747-065f1462f2d2 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | Ambrisentan AMBRISENTAN |
| Letairis | AMBRISENTAN | Gilead Sciences, Inc. | 725d4e73-6c83-477a-adc6-0ae4a133a844 | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | AMBRISENTAN |
| Ambrisentan | AMBRISENTAN | Golden State Medical Supply, Inc. | 4396bab5-2851-62ef-e063-6294a90af76e | 2026-01-27 | Boxed warning, Warnings, Adverse reactions | Ambrisentan AMBRISENTAN |
| Ambrisentan | AMBRISENTAN | Quallent Pharmaceuticals Health LLC | 6fc6032f-94dc-4067-8b24-01990ec99db0 | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | Ambrisentan AMBRISENTAN |
| Ambrisentan | AMBRISENTAN | Mylan Pharmaceuticals Inc. | 8080b009-361b-4505-b09a-0d91a0e4a2c0 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | Ambrisentan AMBRISENTAN |
| ambrisentan | AMBRISENTAN | A-S Medication Solutions | a7dcdea4-d3da-4dc1-9193-6ebdb5b4e690 | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | ambrisentan AMBRISENTAN |
| ambrisentan | AMBRISENTAN | A-S Medication Solutions | fda3e8b5-267b-4690-85c2-78626986245c | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | ambrisentan AMBRISENTAN |
| Ambrisentan | AMBRISENTAN | Actavis Pharma, Inc. | 32549c43-f8ff-422c-b42d-ca0877e661cf | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | Ambrisentan AMBRISENTAN |
| ambrisentan | AMBRISENTAN | Sun Pharmaceutical Industries, Inc. | a4978a54-1799-43d6-85dd-05fa9de0a5d7 | 2025-04-30 | Boxed warning, Warnings, Adverse reactions | ambrisentan AMBRISENTAN |
| Ambrisentan | AMBRISENTAN | Cipla USA Inc. | 0e418384-cae1-47ae-ac5e-afc845d694f6 | 2025-04-22 | Boxed warning, Warnings, Adverse reactions | Ambrisentan AMBRISENTAN |
| ambrisentan | AMBRISENTAN | Aurobindo Pharma Limited | 82e51c75-fb78-4ad3-8bce-5e0581d60014 | 2025-04-21 | Boxed warning, Warnings, Adverse reactions | ambrisentan AMBRISENTAN |
| Ambrisentan | AMBRISENTAN | Zydus Lifesciences Limited | 0e3e3320-27ac-404f-9f01-3d82696e768a | 2024-11-25 | Ambrisentan AMBRISENTAN | |
| AMBRISENTAN | AMBRISENTAN | Sigmapharm Laboratories, LLC | e20ab2fe-bc9f-48a3-b15a-e4bc9532c2ac | 2023-01-10 | Boxed warning, Warnings, Adverse reactions | AMBRISENTAN AMBRISENTAN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
